The challenge of securing reimbursement and funding in Canada
This article was originally published in Clinica
Executive Summary
As the medical device market in Canada continues to evolve, manufacturers both large and small must continuously focus on the two key principles that lead to profitable market access: regulatory authorisation and reimbursement, the "two 'R's" of market access, says Stephen Dibert, president and CEO of Canadian industry association MEDEC.